Our mission is to help improve the health and well–being of people by providing herbal medicines of the highest quality.
Our core values quality, safety and efficacy ensure successful and trustworthy relationship with our stakeholders, and are the foundation for our strategy and success. The values permeate our goals, our products and our way of working.
Our vision is to become leading provider of high quality herbal medicines for the Nordic market by:
The Florealis’ management team consists of individuals with varied backgrounds who all share a common passion for increasing professionalism and quality within the herbal medicine industry.
The team’s experience within the pharmaceutical and medical industry covers most facets of the process of bringing product from the lab to the market.
Kolbrún has a solid background within the pharmaceutical industry and has an extensive knowledge of drug development. Her experience in business strategy and international business development are essential part of her contribution to the team. She believes that key success factors in business are clear goals, good planning and effective teamwork.
Karl has extensive experience in sales, marketing, product management and brand building within the medical field. In recent years he has been an executive in international medical device companies such as Ossur, Biomet and Ekso Bionics. Karl has lead several successful efforts in bringing new medical technologies and products to the markets, both in Europe and the US.
Elsa holds a M.Sc. degree in Pharmacy and Ph.D. degree in Natural Product Chemistry from the University of Iceland. She has experience from both the academy and pharmaceutical industry. Before joining Florealis she worked in the R&D department of Actavis as a clinical scientist, with earlier experience as a project manager and stability scientist.
Ásta holds a Master´s degree in Strategic Management from the University of Iceland. She was with Actavis for 8 years and has extensive experience in collaboration with authorities and strong background in pharmaceutical regulatory procedures.
Our Board of Directors has three experienced veterans of the pharmaceutical, biotech and venture industries.
Mrs Eggertsdóttir is an experienced executive in pharmaceuticals who served on the executive team of Actavis for decades and is now on the board of several healthcare and pharmaceutical companies.
Mr. Pálsson is a CPA and was the CFO of Ossur for 12 years. He is currently on the board of another pharmaceutical company as well as investment funds.
Mr. Ólafsson is the COO and partner at Beringer Finance. He has over 20 years of experience in venture funding and helping companies grow.